| 1. |
Ajmone Marsan N, Delgado V, Shah DJ, et al. Valvular heart disease: shifting the focus to the myocardium. Eur Heart J, 2023, 44(1): 28-40.
|
| 2. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e72-e227.
|
| 3. |
Dragan A, Mateescu AD. Novel biomarkers and advanced cardiac imaging in aortic stenosis: old and new. Biomolecules, 2023, 13(11): 1661.
|
| 4. |
Adhikari R, Shiwakoti S, Ko JY, et al. Oxidative stress in calcific aortic valve stenosis: protective role of natural antioxidants. Antioxidants, 2022, 11(6): 1169.
|
| 5. |
Coisne A, Montaigne D, Aghezzaf S, et al. Clinical outcomes according to aortic stenosis management: insights from real-world practice. J Am Heart Assoc, 2024, 13(22): e036657.
|
| 6. |
中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 中國經導管主動脈瓣置換術臨床路徑專家共識 (2021版). 中國介入心臟病學雜志, 2021, 29(8): 421-436.Structural Cardiology Committee of Cardiovascular Physicians Branch, Chinese Medical Doctor Association. 2021 Expert consensus on clinical pathway for transcatheter aortic valve replacement in China. Chin J Interv Cardiol, 2021, 29(8): 421-436.
|
| 7. |
Gonzales H, Douglas PS, Pibarot P, et al. Left ventricular hypertrophy and clinical outcomes over 5 years after TAVR: an analysis of the PARTNER trials and registries. JACC Cardiovasc Interv, 2020, 13(11): 1329-1339.
|
| 8. |
王墨揚, 周政, 牛冠男, 等. 經導管主動脈瓣置換術2023年度進展. 中國介入心臟病學雜志, 2024, 32(1): 14-19.Wang MY, Zhou Z, Niu GN, et al. Progress of transcatheter aortic valve replacement in 2023. Chin J Interv Cardiol, 2024, 32(1): 14-19.
|
| 9. |
Chen SC, Leu HB, Chang HH, et al. Women had favourable reverse left ventricle remodelling after TAVR. Eur J Clin Invest, 2020, 50(1): e13183.
|
| 10. |
Brankovic M, Sharma A. Transcatheter aortic valve implantation and replacement: the latest advances and prospects. J Clin Med, 2023, 12(6): 1844.
|
| 11. |
Vahanian A, Beyersdorf F, Praz F, et al. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2025, 46(1): 1-116.
|
| 12. |
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation, 2018, 138(20): e618-e651.
|
| 13. |
Généreux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol, 2021, 77(21): 2717-2746.
|
| 14. |
Rehan R, Yong A, Ng M, et al. Coronary microvascular dysfunction: a review of recent progress and clinical implications. Front Cardiovasc Med, 2023, 10: 1111721.
|
| 15. |
Neuhof C, Neuhof H. Calpain system and its involvement in myocardial ischemia and reperfusion injury. World J Cardiol, 2014, 6(7): 638-652.
|
| 16. |
Chaulin AM. The metabolic pathway of cardiac troponins release: mechanisms and diagnostic role. Cardiol Res, 2022, 13(4): 190-205.
|
| 17. |
Treibel TA, Kozor R, Schofield R, et al. Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol, 2018, 71(8): 860-871.
|
| 18. |
Kubala M, de Chillou C, Bohbot Y, et al. Arrhythmias in patients with valvular heart disease: gaps in knowledge and the way forward. Front Cardiovasc Med, 2022, 9: 792559.
|
| 19. |
Kim HS, Park SW, Lee JS, et al. Gender differences in clinical outcomes after transcatheter aortic valve replacement: a meta-analysis. J Am Coll Cardiol, 2021, 77(15): 1922-1933.
|
| 20. |
Zhang J, Chi C, Cha L, et al. Sex differences in reverse left ventricular remodeling in patients who underwent transcatheter aortic valve replacement in a Chinese population. Rev Cardiovasc Med, 2025, 26(8): 39581.
|
| 21. |
Chaulin AM. Cardiac troponins metabolism: from biochemical mechanisms to clinical practice (literature review). Int J Mol Sci, 2021, 22(20): 10928.
|
| 22. |
Kuneman JH, et al. Interaction between sex and left ventricular reverse remodeling and its association with outcomes after transcatheter aortic valve implantation. Int J Cardiovasc Imaging, 2022, 38(9): 1973-1985.
|
| 23. |
El Sherbini AH, Servito M, Zidan A, et al. Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: a meta-analysis. Catheter Cardiovasc Interv, 2024, 103(6): 1-9.
|
| 24. |
Guthoff H, et al. Sex differences in hemodynamics and outcomes after transcatheter aortic valve replacement. Clin Res Cardiol, 2025.
|
| 25. |
Li Y, Pei H, Lou Y, et al. Pre-procedural elevated cardiac troponin predict risk of long-term all-cause mortality after transcatheter aortic valve replacement: a meta-analysis of prospective studies. Biomarkers, 2020, 25(5): 387-393.
|
| 26. |
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults. J Am Soc Echocardiogr, 2015, 28(1): 1-39. e14.
|
| 27. |
Adamo M, Pagnesi M, Chioncel O, et al. Management of aortic stenosis and chronic heart failure: a clinical consensus statement of the HFA and EAPCI of the ESC. Eur J Heart Fail, 2025, 27: 2623-2633.
|
| 28. |
國家心血管病中心國家基本公共衛生服務項目基層高血壓管理辦公室, 國家基層高血壓管理專家委員會. 國家基層高血壓防治管理指南2025版. 中華心血管病雜志, 2025, 53(9): 977-991.The National Essential Public Health Service Program Office for Management of Hypertension in Primary Health Care, National Center for Cardiovascular Diseases, National Committee on Hypertension Management in Primary Health Care. National clinical practice guidelines on the management of hypertension in primary health care in China (2025). Chin J Cardiol, 2025, 53(9): 977-991.
|
| 29. |
中華醫學會糖尿病學分會. 中國糖尿病防治指南 (2024版). 中華糖尿病雜志, 2025, 17(1): 16-139.Chinese Diabetes Society. Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition). Chin J Diabetes, 2025, 17(1): 16-139.
|